Portfolio Holdings Detail for ISIN IE00BMXC7V63

Stock Name / Fund	iShares S&P 500 Paris-Aligned Climate UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	UPABz(USD) CXE
ETF Ticker	UQAB.DE(EUR) CXE
ETF Ticker	UPAB(USD) Euronext Amsterdam

Holdings detail for SYK

Show aggregate SYK holdings

News associated with SYK

Noteworthy ETF Inflows: VUG, BSX, SYK, APH

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Growth ETF (Symbol: VUG) where we have detected an approximate $1.9 billion dollar inflow -- that's a 1.0% increase week over week in outsta - 2025-09-09 11:51:27

Stryker Corporation (NYSE:SYK) Receives $430.10 Consensus Target Price from Brokerages

Shares of Stryker Corporation (NYSE:SYK – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the nineteen ratings firms that are presently covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The average […] - 2025-09-08 02:50:50

Analysts Set Stryker Corporation (NYSE:SYK) Price Target at $430.10

Shares of Stryker Corporation (NYSE:SYK – Get Free Report) have earned a consensus rating of “Moderate Buy” from the nineteen brokerages that are presently covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and fifteen have given a buy recommendation to the company. The average 1-year price […] - 2025-08-14 02:48:56

The Health Care Select Sector SPDR Fund Experiences Big Outflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $547.2 million dollar outflow -- that's a 1.7% decrease - 2025-08-12 11:56:08

4 GARP Stocks That Investors Can Scoop Up for Maximum Returns

Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. RL, SYK, RGLD and ADSK hold promise. - 2025-08-12 11:44:00

Noteworthy ETF Outflows: XLV, PFE, SYK, DHR

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $190.1 million dollar outflow -- that's a 0.6% decrease - 2025-08-04 11:50:53

After-Hours Earnings Report for July 31, 2025 : AAPL, AMZN, SYK, KLAC, MSTR, COIN, AJG, NET, RMD, MPWR, IR, LPLA

The following companies are expected to report earnings after hours on 07/31/2025. Visit our Earnings Calendar for a full list of expected earnings releases.Apple Inc. (AAPL)is reporting for the quarter ending June 30, 2025. The computer company's consensus earnings per share fo - 2025-07-31 15:00:01

See Which Of The Latest 13F Filers Holds SYK

At Holdings Channel, we have reviewed the latest batch of the 28 most recent 13F filings for the 06/30/2025 reporting period, and noticed that Stryker Corp (Symbol: SYK) was held by 12 of these funds. When hedge fund managers appear to be thinking alike, we find it is a good ide - 2025-07-24 12:22:30

Noteworthy ETF Inflows: SCHX, HON, SYK, PANW

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Schwab US Large-Cap ETF (Symbol: SCHX) where we have detected an approximate $119.3 million dollar inflow -- that's a 0.2% increase week over week in - 2025-07-24 11:48:21

Should You Buy or Sell Boston Scientific Stock Ahead of Its Upcoming Earnings?

Boston Scientific (NYSE:BSX) is scheduled to report its earnings on Wednesday, July 23, 2025. - 2025-07-23 16:13:59

Stryker Corporation (NYSE:SYK) Stock Position Raised by Edgestream Partners L.P.

Edgestream Partners L.P. boosted its position in shares of Stryker Corporation (NYSE:SYK – Free Report) by 27.0% during the 1st quarter, HoldingsChannel reports. The firm owned 893 shares of the medical technology company’s stock after buying an additional 190 shares during the quarter. Edgestream Partners L.P.’s holdings in Stryker were worth $332,000 at the end […] - 2025-07-21 04:56:50

Fund Update: GREENLEAF TRUST Just Disclosed New Holdings

GREENLEAF TRUST just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 06-30-2025 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-07-17 18:15:54

Should You Buy or Sell Abbott Laboratories Stock Ahead of Its Upcoming Earnings?

Abbott Laboratories (NYSE:ABT) is set to release its second-quarter earnings on Thursday, July 17, 2025. For event-driven traders, analyzing the stock’s historical reactions to earnings reports can provide valuable insights. - 2025-07-16 02:32:25

Allspring Global Investments Holdings LLC Sells 1,093 Shares of Stryker Corporation (NYSE:SYK)

Allspring Global Investments Holdings LLC reduced its stake in Stryker Corporation (NYSE:SYK – Free Report) by 2.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,368 shares of the medical technology company’s stock after selling 1,093 shares during the quarter. Allspring Global […] - 2025-07-03 05:31:05

Wednesday Sector Leaders: Technology & Communications, Healthcare

Looking at the sectors faring best as of midday Wednesday, shares of Technology & Communications companies are outperforming other sectors, losing just 0.2%. Within that group, Super Micro Computer Inc (Symbol: SMCI) and NVIDIA Corp (Symbol: NVDA) are two large stocks leadin - 2025-06-25 15:51:09

Analysts Set Stryker Corporation (NYSE:SYK) Target Price at $427.30

Shares of Stryker Corporation (NYSE:SYK – Get Free Report) have earned an average recommendation of “Moderate Buy” from the nineteen research firms that are presently covering the company, Marketbeat.com reports. Four analysts have rated the stock with a hold rating and fifteen have issued a buy rating on the company. The average twelve-month target price […] - 2025-06-25 02:44:54

Advisor Resource Council Acquires New Stake in Stryker Corporation (NYSE:SYK)

Advisor Resource Council bought a new position in Stryker Corporation (NYSE:SYK – Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 848 shares of the medical technology company’s stock, valued at approximately $316,000. Several other institutional investors and hedge funds […] - 2025-06-24 05:22:59

The Implied Analyst 12-Month Target For IVW

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-23 08:46:08

Robertson Stephens Wealth Management LLC Sells 284 Shares of Stryker Corporation (NYSE:SYK)

Robertson Stephens Wealth Management LLC lowered its holdings in Stryker Corporation (NYSE:SYK – Free Report) by 30.7% during the 1st quarter, HoldingsChannel.com reports. The firm owned 641 shares of the medical technology company’s stock after selling 284 shares during the quarter. Robertson Stephens Wealth Management LLC’s holdings in Stryker were worth $239,000 as of its […] - 2025-06-20 05:41:07

Stryker (NYSE:SYK) versus NAYA Biosciences (NASDAQ:NAYA) Financial Contrast

NAYA Biosciences (NASDAQ:NAYA – Get Free Report) and Stryker (NYSE:SYK – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk and profitability. Profitability This table compares NAYA Biosciences and Stryker’s net […] - 2025-06-20 04:26:53

Exchange Traded Concepts LLC Purchases 429 Shares of Stryker Corporation (NYSE:SYK)

Exchange Traded Concepts LLC lifted its position in shares of Stryker Corporation (NYSE:SYK – Free Report) by 6.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,692 shares of the medical technology company’s stock after purchasing an additional 429 […] - 2025-06-18 07:36:50

Trust Point Inc. Sells 894 Shares of Stryker Corporation (NYSE:SYK)

Trust Point Inc. reduced its stake in shares of Stryker Corporation (NYSE:SYK – Free Report) by 47.4% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 991 shares of the medical technology company’s stock after selling 894 shares during the period. Trust Point Inc.’s holdings in Stryker […] - 2025-06-18 05:11:09

Stryker Co. (NYSE:SYK) Shares Acquired by Ritholtz Wealth Management

Ritholtz Wealth Management raised its holdings in shares of Stryker Co. (NYSE:SYK – Free Report) by 5.2% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 5,598 shares of the medical technology company’s stock after acquiring an additional 276 shares during the quarter. […] - 2025-06-17 07:38:45

Dynamic Advisor Solutions LLC Takes Position in Stryker Co. (NYSE:SYK)

Dynamic Advisor Solutions LLC purchased a new stake in shares of Stryker Co. (NYSE:SYK – Free Report) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 6,388 shares of the medical technology company’s stock, valued at approximately $2,378,000. Several other hedge funds and other […] - 2025-06-17 05:46:52

Buy, Sell, Or Hold Boston Scientific Stock At $100?

Boston Scientific (NYSE:BSX) has seen its stock price surge over 30% in the past twelve months, significantly outpacing the S&P 500’s 9% gain. This impressive performance is attributed to new product launches, which have bolstered sales growth and expanded profit margin - 2025-06-17 03:35:45

Assenagon Asset Management S.A. Buys 110 Shares of Stryker Co. (NYSE:SYK)

Assenagon Asset Management S.A. lifted its stake in Stryker Co. (NYSE:SYK – Free Report) by 1.1% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,375 shares of the medical technology company’s stock after purchasing an additional 110 shares during […] - 2025-06-16 05:06:59

Focus Financial Network Inc. Takes $214,000 Position in Stryker Co. (NYSE:SYK)

Focus Financial Network Inc. purchased a new stake in Stryker Co. (NYSE:SYK – Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 576 shares of the medical technology company’s stock, valued at approximately $214,000. A number of other hedge funds and […] - 2025-06-15 05:58:52

5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off

Volatility is a part of life for long-term investors. The reasons the market goes up or down change, but the constant is that high-quality stocks, businesses that increasingly make more money over time, will reward investors if you wait long enough. - 2025-06-11 06:00:00

Vest Financial LLC Acquires New Holdings in Stryker Co. (NYSE:SYK)

Vest Financial LLC bought a new position in Stryker Co. (NYSE:SYK – Free Report) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 545 shares of the medical technology company’s stock, valued at approximately $203,000. Other institutional investors and hedge funds have also bought and sold shares […] - 2025-06-09 05:51:03

Notable ETF Outflow Detected - IXJ, SYK, DHR, MDT

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Global Healthcare ETF (Symbol: IXJ) where we have detected an approximate $116.0 million dollar outflow -- that's a 3.0% decrease week over - 2025-06-03 12:36:10

iShares S&P 500 Paris-Aligned Climate UCITS ETF USD (Acc) SYK holdings

Date	Number of SYK Shares Held	Base Market Value of SYK Shares	Local Market Value of SYK Shares	Change in SYK Shares Held	Change in SYK Base Value	Current Price per SYK Share Held	Previous Price per SYK Share Held
2025-12-02 (Tuesday)	2,853	USD 1,046,138	USD 1,046,138	-66	USD -40,664	USD 366.68	USD 372.32
2025-12-01 (Monday)	2,919	USD 1,086,802	USD 1,086,802	0	USD 3,328	USD 372.32	USD 371.18
2025-11-28 (Friday)	2,919	USD 1,083,474	USD 1,083,474	-22	USD -19,636	USD 371.18	USD 375.08
2025-11-25 (Tuesday)	2,941	USD 1,103,110	USD 1,103,110	22	USD 22,438	USD 375.08	USD 370.22
2025-11-24 (Monday)	2,919	USD 1,080,672	USD 1,080,672	0	USD 5,692	USD 370.22	USD 368.27
2025-11-21 (Friday)	2,919	USD 1,074,980	USD 1,074,980	0	USD 22,739	USD 368.27	USD 360.48
2025-11-20 (Thursday)	2,919	USD 1,052,241	USD 1,052,241	-11	USD -1,153	USD 360.48	USD 359.52
2025-11-18 (Tuesday)	2,930	USD 1,053,394	USD 1,053,394	0	USD -1,787	USD 359.52	USD 360.13
2025-11-17 (Monday)	2,930	USD 1,055,181	USD 1,055,181	-88	USD -37,999	USD 360.13	USD 362.22

Share Trades of SYK by Blackrock for IE00BMXC7V63

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	SELL	-66			366.680*		377.90 Profit of 24,942 on sale
2025-11-28	SELL	-22			371.180*		377.96 Profit of 8,315 on sale
2025-11-25	BUY	22			375.080*		377.97
2025-11-20	SELL	-11			360.480*		378.14 Profit of 4,160 on sale
2025-11-17	SELL	-88			360.130*		378.32 Profit of 33,292 on sale
2025-11-03	SELL	-275	360.650	353.860	354.539	EUR -97,498	379.17 Profit of 6,775 on sale
2025-10-31	BUY	11	369.420	355.730	357.099	EUR 3,928	379.29
2025-10-23	SELL	-44	383.060	388.610	388.055	EUR -17,074	379.36 Loss of -383 on sale
2025-10-22	SELL	-22	388.350	392.550	392.130	EUR -8,627	379.31 Loss of -282 on sale
2025-10-01	SELL	-11	364.150	371.170	370.468	EUR -4,075	379.69 Profit of 101 on sale
2025-09-29	SELL	-187	369.880	369.890	369.889	EUR -69,169	379.80 Profit of 1,854 on sale
2025-09-18	BUY	11	377.840	378.150	378.119	EUR 4,159	379.94
2025-09-10	SELL	-22	382.970	392.950	391.952	EUR -8,623	379.96 Loss of -264 on sale
2025-08-20	BUY	55	391.870	395.370	395.020	EUR 21,726	379.63
2025-08-15	SELL	-22	381.910	383.140	383.017	EUR -8,426	379.54 Loss of -77 on sale
2025-07-15	SELL	-77	390.590	392.770	392.552	EUR -30,227	378.39 Loss of -1,090 on sale
2025-07-11	SELL	-99	389.460	392.990	392.637	EUR -38,871	378.23 Loss of -1,426 on sale
2025-07-09	SELL	-22	392.050	392.790	392.716	EUR -8,640	378.03 Loss of -323 on sale
2025-07-03	SELL	-22	395.280	395.500	395.478	EUR -8,701	377.61 Loss of -393 on sale
2025-07-02	SELL	-110	391.810	396.820	396.319	EUR -43,595	377.52 Loss of -2,068 on sale
2025-06-30	SELL	-319	395.630	395.870	395.846	EUR -126,275	377.39 Loss of -5,887 on sale
2025-06-20	BUY	284	375.560	377.900	377.666	EUR 107,257	377.01
2025-06-13	SELL	-80	377.300	382.350	381.845	EUR -30,548	377.09 Loss of -381 on sale
2025-06-12	SELL	-60	380.490	381.590	381.480	EUR -22,889	377.06 Loss of -265 on sale
2025-06-11	SELL	-180	381.080	385.420	384.986	EUR -69,297	377.03 Loss of -1,432 on sale
2025-06-10	SELL	-220	385.050	386.290	386.166	EUR -84,957	376.97 Loss of -2,023 on sale
2025-06-05	BUY	60	383.100	384.600	384.450	EUR 23,067	376.82
2025-05-19	SELL	-10	394.690	394.920	394.897	EUR -3,949	376.21 Loss of -187 on sale
2025-05-13	BUY	30	387.530	390.460	390.167	EUR 11,705	375.70
2025-05-02	BUY	40	378.220	379.330	379.219	EUR 15,169	375.29
2025-05-01	SELL	-50	373.990	376.180	375.961	EUR -18,798	375.30 Loss of -33 on sale
2025-04-28	SELL	-170	366.490	368.950	368.704	EUR -62,680	375.45 Profit of 1,147 on sale
2025-04-16	BUY	40	346.670	352.580	351.989	EUR 14,080	377.57
2025-04-08	BUY	60	337.370	357.470	355.460	EUR 21,328	379.52
2025-04-07	SELL	-160	345.340	357.590	356.365	EUR -57,018	379.93 Profit of 3,771 on sale
2025-04-04	SELL	-30	345.800	362.070	360.443	EUR -10,813	380.34 Profit of 597 on sale
2025-03-28	SELL	-500	364.500	368.510	368.109	EUR -184,055	380.77 Profit of 6,331 on sale
2025-03-27	SELL	-20	367.540	370.000	369.754	EUR -7,395	380.94 Profit of 224 on sale
2025-03-24	SELL	-20	374.270	377.230	376.934	EUR -7,539	381.31 Profit of 88 on sale
2025-03-21	SELL	-687	371.110	374.790	374.422	EUR -257,228	381.45 Profit of 4,829 on sale
2025-03-18	SELL	-264	375.910	376.720	376.639	EUR -99,433	381.68 Profit of 1,331 on sale
2025-03-14	SELL	-77	369.530	371.760	371.537	EUR -28,608	381.97 Profit of 804 on sale
2025-03-13	SELL	-11	363.660	367.280	366.918	EUR -4,036	382.24 Profit of 169 on sale
2025-03-12	BUY	110	363.840	371.110	370.383	EUR 40,742	382.52
2025-03-11	BUY	143	365.290	369.520	369.097	EUR 52,781	382.78
2025-03-07	BUY	66	379.300	381.000	380.830	EUR 25,135	383.03
2025-03-05	BUY	143	395.690	398.000	397.769	EUR 56,881	382.83
2025-02-26	BUY	22	391.740	396.670	396.177	EUR 8,716	382.18
2025-02-12	BUY	22	385.630	389.730	389.320	EUR 8,565	381.27
2025-02-05	BUY	44	399.090	399.850	399.774	EUR 17,590	379.79
2025-01-02	BUY	1,188	358.720	362.480	362.104	EUR 430,180	376.76
2024-12-09	SELL	-9	381.110	385.150	384.746	EUR -3,463	376.43 Loss of -75 on sale
2024-12-03	SELL	-18	390.970	391.900	391.807	EUR -7,053	374.86 Loss of -305 on sale
2024-12-02	BUY	9	389.630	394.140	393.689	EUR 3,543	374.29
2024-11-29	BUY	18	392.150	393.300	393.185	EUR 7,077	373.58
2024-11-27	BUY	45	388.140	391.400	391.074	EUR 17,598	372.31
2024-11-26	BUY	54	389.710	389.950	389.926	EUR 21,056	371.52
2024-11-22	BUY	18	384.850	391.070	390.448	EUR 7,028	370.18
2024-11-19	BUY	18	388.680	392.310	391.947	EUR 7,055	367.01
2024-11-18	BUY	27	389.400	398.200	397.320	EUR 10,728	365.61
2024-11-12	BUY	9	387.110	388.120	388.019	EUR 3,492	364.18
2024-11-05	BUY	90	369.860	370.290	370.247	EUR 33,322	361.64
2024-10-31	BUY	36	356.280	364.010	363.237	EUR 13,077	360.96
2024-10-30	BUY	135	363.430	373.730	372.700	EUR 50,315	360.61
2024-10-21	BUY	18	367.250	370.970	370.598	EUR 6,671	0.00

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of SYK

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy